scholarly journals Esophagopleural fistula treated with muscular ventricular septal defect occluder

Author(s):  
Rafael Vera-Urquiza ◽  
José M. Esteban López-Jamar ◽  
Luis Nombela-Franco ◽  
Manuel Vázquez Romero ◽  
Carolina Espejo ◽  
...  
1970 ◽  
Vol 25 (3) ◽  
pp. 161-163
Author(s):  
Nurun Nahar Fatema ◽  
Mamunur Rahman ◽  
Mujubul Haque

A four year old girl was diagnosed as a case of mid muscular Ventricular Septal Defect (VSD) since early infancy. She had history of failure to thrive (FTT) and recurrent chest infection or pneumonia. As her pulmonary artery pressure was almost normal she was planned for device closure on elective basis once device and technology would be available in cardiac centre of combined Military Hospital (CMH) Dhaka. Finally it was done on 21st August 2005 and patient was discharged after 72 hours observation period. Echocardiography on next morning showed complete occlusion of defect with no residual shunt. (J Bangladesh Coll Phys Surg 2007; 25 : 161-163)


1996 ◽  
Vol 78 (10) ◽  
pp. 1183-1185 ◽  
Author(s):  
Zhong-Dong Du ◽  
Nathan Roguin ◽  
Mila Barak ◽  
Sandra Glusman Bihari ◽  
Mordechai Ben-Elisha

2014 ◽  
Vol 6 (1) ◽  
pp. 59-66 ◽  
Author(s):  
Arvind Kumar Bishnoi ◽  
Pankaj Garg ◽  
Manan Desai ◽  
Pranav Sharma ◽  
Jigar Patel ◽  
...  

2020 ◽  
Vol 13 (6) ◽  
pp. e236264 ◽  
Author(s):  
Kelsey Danley ◽  
Paul Kent

A 4-month-old boy with a history of muscular ventricular septal defect and atopic dermatitis presented with decreased oral intake, loose stools, stuffy nose, mild cough and diaphoresis. The patient had an in-home exposure to COVID-19. The initial respiratory pathogen panel was positive for adenovirus, consistent with his symptoms. The following day, the COVID-19 PCR was also positive. The patient was treated with supportive care, isolation precautions were implemented and the patient was discharged on day 4. This case demonstrates the importance of testing for COVID-19 even if a patient tests positive for another virus due to the possibility of coinfection, especially in children, in order to limit spread of COVID-19 to others.


2020 ◽  
Vol 30 (10) ◽  
pp. 1517-1520
Author(s):  
Raymond N. Haddad ◽  
Régis Gaudin ◽  
Damien Bonnet ◽  
Sophie Malekzadeh-Milani

AbstractThe hybrid perventricular approach for the closure of trabecular ventricular septal defects is an attractive treatment modality for small children. Worldwide experience has shown that procedure success is influenced by the defect anatomical accessibility, operators’ expertise, and device technical features. In May 2018, a new promising device, the KONAR-Multi-functional™ ventricular septal defect occluder (Lifetech, Shenzhen, China), obtained CE-marking for septal defect transcatheter closure after the first-in-man implantation in 2013. Herein, this is the first report of successful perventricular closure of ventricular septal defect using this new device in a child with significant co-morbidities.


1995 ◽  
Vol 26 (6) ◽  
pp. 1545-1548 ◽  
Author(s):  
Nathan Roguin ◽  
Zhong-Dong Du ◽  
Mila Barak ◽  
Nadim Nasser ◽  
Sylvia Hershkowitz ◽  
...  

2011 ◽  
Vol 22 (1) ◽  
pp. 113-115
Author(s):  
Jayaranganath Mahima ◽  
Devananda Nijagal Shivanna ◽  
Anand Subramanian

AbstractArterial switch surgery for d-transposition of great arteries is usually performed in the first 2 weeks of life before the left ventricle regresses. The arterial switch surgery that helps achieve anatomic and physiologic correction of this condition has better long-term outcomes than other surgical approaches. The procedure may still be attempted at an older age where the left ventricle has not regressed. We report a rare case of a 12-year-old child with d-transposition of great arteries, a remote muscular ventricular septal defect and isolated valvar pulmonic stenosis, which was corrected by an arterial switch surgery.


Sign in / Sign up

Export Citation Format

Share Document